These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29371981)

  • 1. Suppressor of fused (Sufu) promotes epithelial-mesenchymal transition (EMT) in cervical squamous cell carcinoma.
    Zhang Z; Zou Y; Liang M; Chen Y; Luo Y; Yang B; Liu F; Qin Y; He D; Wang F; Huang O
    Oncotarget; 2017 Dec; 8(69):114226-114238. PubMed ID: 29371981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.
    Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H
    Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placenta growth factor promotes migration through regulating epithelial-mesenchymal transition-related protein expression in cervical cancer.
    Huang W; Zhu S; Liu Q; Li C; Li L
    Int J Clin Exp Pathol; 2014; 7(12):8506-19. PubMed ID: 25674215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition.
    Chen X; Lan K; Liu Q; Yang X; Wang H
    Tumour Biol; 2017 Mar; 39(3):1010428317695942. PubMed ID: 28351308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
    Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
    Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer.
    He SY; Shen HW; Xu L; Zhao XH; Yuan L; Niu G; You ZS; Yao SZ
    Gynecol Oncol; 2012 Dec; 127(3):601-10. PubMed ID: 22943878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of suppressor-of-fused function promotes tumorigenesis.
    Lee Y; Kawagoe R; Sasai K; Li Y; Russell HR; Curran T; McKinnon PJ
    Oncogene; 2007 Sep; 26(44):6442-7. PubMed ID: 17452975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.
    Kong FF; Qu ZQ; Yuan HH; Wang JY; Zhao M; Guo YH; Shi J; Gong XD; Zhu YL; Liu F; Zhang WY; Jiang B
    Oncol Rep; 2014 Jun; 31(6):2660-8. PubMed ID: 24715097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer.
    Yang C; Chen H; Tan G; Gao W; Cheng L; Jiang X; Yu L; Tan Y
    Cancer Lett; 2013 Oct; 340(1):104-12. PubMed ID: 23856032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCL/TAL1 interrupting locus derepresses GLI1 from the negative control of suppressor-of-fused in pancreatic cancer cell.
    Kasai K; Inaguma S; Yoneyama A; Yoshikawa K; Ikeda H
    Cancer Res; 2008 Oct; 68(19):7723-9. PubMed ID: 18829525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPOP-PTEN-SUFU axis promotes progression of clear cell renal cell carcinoma via activating SHH and WNT pathway.
    Han B; Sun Z; Yu T; Wang Y; Kuang L; Li T; Cai J; Cao Q; Xu Y; Gao B; Cheng SY; Yue S; Liu C
    Cell Death Discov; 2021 May; 7(1):120. PubMed ID: 34021128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor kinase substrate 8 promotes the metastasis of cervical cancer via the epithelial-mesenchymal transition.
    Li Q; Bao W; Fan Q; Shi WJ; Li ZN; Xu Y; Wu D
    Mol Med Rep; 2016 Oct; 14(4):3220-8. PubMed ID: 27573546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of FoxM1 leads to the inhibition of the epithelial-mesenchymal transition in gastric cancer cells.
    Miao L; Xiong X; Lin Y; Cheng Y; Lu J; Zhang J; Cheng N
    Cancer Genet; 2014 Mar; 207(3):75-82. PubMed ID: 24726291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
    Wierstra I
    Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines.
    Deng B; Zhang S; Miao Y; Zhang Y; Wen F; Guo K
    Med Oncol; 2015 Apr; 32(4):102. PubMed ID: 25740178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling.
    Peake BF; Eze SM; Yang L; Castellino RC; Nahta R
    Oncotarget; 2017 Nov; 8(55):94393-94406. PubMed ID: 29212236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
    Xu R; Hu J; Zhang T; Jiang C; Wang HY
    Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-630 Suppresses Epithelial-to-Mesenchymal Transition by Regulating FoxM1 in Gastric Cancer Cells.
    Feng J; Wang X; Zhu W; Chen S; Feng C
    Biochemistry (Mosc); 2017 Jun; 82(6):707-714. PubMed ID: 28601080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiRNA-194 activates the Wnt/β-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU.
    Peng Y; Zhang X; Ma Q; Yan R; Qin Y; Zhao Y; Cheng Y; Yang M; Wang Q; Feng X; Huang Y; Huang W; Zhao Z; Wang L; Wei Y; He Z; Fan X; Li S; Jin Z; Meltzer SJ
    Cancer Lett; 2017 Jan; 385():117-127. PubMed ID: 27810403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.